The United Kingdom has officially lost its status of measles elimination as recognized by the World Health Organization (WHO), and this development comes with serious implications. Despite being deemed free of the disease from 2021 to 2023, health authorities have reported a resurgence of measles cases in the UK starting in 2024, raising alarm bells among global health officials.
Recent statistics reveal that vaccination rates have stagnated, leading to a dramatic increase in measles infections, which reached a staggering total of 3,681 cases in 2024 alone. This troubling trend is not isolated; countries such as Spain, Austria, Armenia, Azerbaijan, and Uzbekistan have also faced similar setbacks in maintaining their measles elimination status. The WHO has urgently called on nations to enhance their vaccination efforts to protect children from this preventable disease.
Dr. Ben Kasstan-Dabush, an assistant professor of global health at the London School of Hygiene and Tropical Medicine, emphasized that the loss of elimination status in the UK is hardly surprising given the outbreaks that have occurred nationwide since 2024, including the tragic incident of a child's preventable death in 2025.
According to the latest data from the UK Health Security Agency (UKHSA), only 83.7% of five-year-olds received both doses of the MMR (measles, mumps, and rubella) vaccine in the 2024-2025 period. This figure marks a slight decrease from 83.9% the previous year and represents the lowest vaccination coverage recorded since the 2009-2010 period. In addition, while 91.9% of five-year-olds received at least one dose of the MMR vaccine, this statistic remained unchanged from the previous year, indicating a concerning stagnation in vaccination efforts.
The WHO recommends that at least 95% of children receive vaccinations for each disease to achieve herd immunity, which is crucial for preventing widespread outbreaks. Dr. Vanessa Saliba, a consultant epidemiologist at the UKHSA, stated, "Infections can return quickly when childhood vaccine uptake falls," highlighting the need for comprehensive vaccination coverage. She also stressed the importance of ensuring that all eligible children receive two doses of the MMR vaccine before they begin school and that older children and adults who have missed their vaccinations need to be updated as soon as possible.
In response to the rising cases, the UK has introduced a new combined MMRV vaccine in January 2025, which protects against measles, mumps, rubella, and chickenpox, replacing the previous MMR vaccine in the standard two-dose childhood vaccination schedule. The first dose is now administered at one year of age, while the second dose has been moved up from three years and four months to 18 months. This change follows recommendations made by the Joint Committee on Vaccination and Immunisation (JCVI) in 2023.
A spokesperson from the WHO remarked that the UK's loss of measles elimination status reflects a wider issue currently faced across Europe, where outbreaks of measles and other vaccine-preventable diseases pose significant threats to public health security. Dr. Bharat Pankhania, a senior clinical lecturer in public health medicine at the University of Exeter Medical School, expressed deep concern over the emergence of areas within the UK exhibiting low or nonexistent vaccine uptake, emphasizing the urgent need for action to address this critical situation.
